Search for: "SMITH v. ELI LILLY & COMPANY" Results 21 - 36 of 36
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
24 Feb 2011, 1:49 pm by Bexis
The complicated medical terminology necessary to explain the risk/benefit profile of prescription drugs/devices is difficult for ordinary patients to understand.Practical difficulties often preclude drug/device companies from direct communication with patients.But plaintiffs don’t make direct-to-patient warning claims only against drug/device companies. [read post]
22 Jan 2009, 2:06 am
Thus the plaintiff could proceed against the non-manufacturer pioneer company, even though the plaintiff's claims against the actual manufacturers were properly dismissed on warning causation grounds. [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
25 Jul 2011, 1:07 am by Melina Padron
will be decided this week, this time by the European Patent Office in Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
6 Jul 2007, 4:29 am
Thus, at best, Karl has just created a regime of redundant and overlapping liability with the patients stuck in the middle - not knowing whom to believe if doctors and drug companies say different things.The learned intermediary rule thus makes sound practical sense. [read post]
15 Mar 2008, 7:00 am
  Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market:… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
2 Aug 2014, 6:05 am by Schachtman
Smith Corp., Circuit Court of Illinois, Third Judicial Circuit (Dec. 22, 2004). [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One lot of Glucagon Emergency Kits have been recalled by Eli Lilly and Company due to a potentially dangerous loss of potency. [read post]
29 Jan 2024, 4:35 pm
Website: http://cates1980.wixsite.com/cateswebsite Facebook Page: https://www.facebook.com/robert.piller.3979  Jeffrey Smith GE SOIL MICROBES NEW TARGET FOR AGRICHEMICAL COMPANIES. [read post]